BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/22/2022 9:25:38 AM | Browse: 258 | Download: 627
Publication Name World Journal of Hepatology
Manuscript ID 73421
Country Egypt
Received
2021-11-20 19:35
Peer-Review Started
2021-11-20 19:37
To Make the First Decision
Return for Revision
2021-12-28 19:46
Revised
2022-01-08 01:36
Second Decision
2022-02-14 05:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-02-16 07:17
Articles in Press
2022-02-16 07:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-02-17 07:03
Publish the Manuscript Online
2022-02-22 09:25
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
Manuscript Source Invited Manuscript
All Author List Sameh A Lashen, Mohammed M Shamseya, Marwa A Madkour, Radwa M Abdel Salam and Sanaa S Mostafa
ORCID
Author(s) ORCID Number
Sameh A Lashen http://orcid.org/0000-0002-8599-1338
Mohammed M Shamseya http://orcid.org/0000-0002-7145-6588
Marwa A Madkour http://orcid.org/0000-0003-2152-7939
Radwa M Abdel Salam http://orcid.org/0000-0002-4125-4475
Sanaa S Mostafa http://orcid.org/0000-0002-8468-060X
Funding Agency and Grant Number
Corresponding Author Sameh A Lashen, MD, PhD, Associate Professor, Internal Medicine (Hepatology and Gastroenterology division), Faculty of Medicine, Alexandria University, Champollion Street, El-Khartoum Square, Azarita Medical Campus, Alexandria 21521, Egypt. sameh.lashen@alexmed.edu.eg
Key Words β-arrestin-2; Portal hypertension; Variceal bleeding; Nonselective beta-blockers; Portal congestion index; Variceal ligation
Core Tip Gastric antral β-Arrestin-2 (β-Arr-2) expression correlates to portal hypertension in terms of esophageal varices and portal gastropathy. A stronger β-Arr-2 expression is associated with a sustained clinical response to nonselective β-blockers (NSBB) with a longer variceal bleeding-free interval. Patients who experienced variceal bleeding while on NSBB had lower baseline serum and tissue expression of β-Arr-2. In patients with responded to NSBB, the expression of β-Arr-2 was reduced after long-term treatment. The serum level of β-Arr-2 correlates to its antral expression and showed high sensitivity and specificity for defining the subgroup of patients who will respond to NSBB.
Publish Date 2022-02-22 09:25
Citation Lashen SA, Shamseya MM, Madkour MA, Abdel Salam RM, Mostafa SS. β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study. World J Hepatol 2022; 14(2): 429-441
URL https://www.wjgnet.com/1948-5182/full/v14/i2/429.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i2.429
Full Article (PDF) WJH-14-429.pdf
Full Article (Word) WJH-14-429.docx
Manuscript File 73421_Auto_Edited-LJH.docx
Answering Reviewers 73421-Answering reviewers.pdf
Audio Core Tip 73421-Audio core tip.m4a
Biostatistics Review Certificate 73421-Biostatistics statement.pdf
Clinical Trial Registration Statement 73421-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form 73421-Conflict-of-interest statement.pdf
Copyright License Agreement 73421-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 73421-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 73421-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 73421-Language certificate.pdf
Supplementary Material 73421-Supplementary material.pdf
Peer-review Report 73421-Peer-review(s).pdf
Scientific Misconduct Check 73421-Bing-Liu JH-2.jpg
Scientific Misconduct Check 73421-CrossCheck.jpg
Scientific Editor Work List 73421-Scientific editor work list.pdf